NOT-99-151: INACTIVATION: HIV VACCINE RESEARCH AND DESIGN

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.

INACTIVATION: HIV VACCINE RESEARCH AND DESIGN - R01 GRANTS Release Date: October 4, 1999 PA NUMBER: PA-98-089 National Institute of Allergy and Infectious Diseases The National Institute of Allergy and Infectious Diseases (NIAID) is inactivating program announcement PA 98-089, HIV VACCINE RESEARCH AND DESIGN RESEARCH PROJECT GRANTS, which appeared in the NIH Guide, July 9, 1998. The areas of investigator-initiated vaccine research this PA targeted have received numerous responses that have been well-received in the NIH peer review system. Accordingly NIAID will no longer give special consideration for funding to applications in response to this PA received after January 2, 2000. NIAID will, however, continue to give special consideration for funding to applications in response to PAR 98-090, HIV VACCINE RESEARCH AND DESIGN PROGRAM PROJECT GRANTS, which also appeared in the NIH Guide, July 9, 1998. NIAID supports highly scientifically meritorious applications in all areas of research within its mission. PA inactivation simply means that special consideration for funding beyond normal paylines will NO LONGER be given to applications on the research topics identified in the inactivated PAs. However, such applications will be accepted, reviewed, and considered for funding according the usual procedures. At any time, potential applicants can obtain a current listing of active NIAID PAs on the NIAID WWW site at URL: http://www.niaid.nih.gov/ncn/budget/pas.htm INQUIRIES For questions or further information, contact: Steve Bende, Ph.D. NIH, NIAID, VPRP Room 4107 6700-B Rockledge Drive MSC 7628 Bethesda, MD 20892-7628 Telephone: (301) 435-3756 Fax: (301) 402-3684 Email: sb22k@nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices